Companies · Medical Devices

Curadel Surgical Innovations, Inc.

Bonita Springs · Medical Devices · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Curadel Surgical Innovations, Inc. — recommendation, valuation, rhythm, risks.
$26.0M
Total raised · real
3
Rounds
1.5×
Latest step-up
Top 11%
Sector rank · raised
Series A
Latest stage · inferred · Thu Sep 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Curadel Surgical Innovations, Inc. looks over-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the medical devices sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 4.27× the median modeled value of Series A Medical Devices companies in 2025–2027 (10 peers) — value vs value, same stage and era.
Active
  • Last raise 9 mo ago; this sector typically re-raises about every 16 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Medical Devices

Curadel Surgical Innovations, Inc. is one of 233 Medical Devices companies tracked from Bonita Springs. By capital raised it ranks among the largest (ahead of 90% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

medical-devices

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
25
Investors (latest)
2025-09-25
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MSeed · 2023-06-05 Raised $2.0M (real) Modeled valuation $15M (est)$2.0M$15MSeed2023Series A · 2024-09-04 Raised $7.5M (real) Modeled valuation $35M (est)$7.5M$35MSeries A2024Series A · 2024-09-04 Raised $9.5M (real) Modeled valuation $44M (est)$9.5M$44MSeries A2024Series A · 2025-09-25 Raised $14M (real) Modeled valuation $44M (est)$14M$44MSeries A2025+$7.5M+$9.5M+$14MCumulative $34M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.0M · 2023
Series A$7.5M · 2024
Series A extension$9.5M · 2024
Series A extension$14.5M · 2025

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$44.1M
Base estimate est.
$17.8M
Conservative case
$71.8M
Upside case
$65.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the medical devices sector profile. Directional, not a quoted figure.

Seed · modeled $15.1M · 2023-06-052023Series A · modeled $34.7M · 2024-09-04Series A · modeled $44.1M · 2024-09-04Series A · modeled $44.1M · 2025-09-252025
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
50%
Survival probability
27% low · 68% high
1.49×/yr
Annual markup
1.87×/yr upside case
0.8 yr
Elapsed time used
0.8 yr actual, capped for stale marks
medical devices
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
9 mo
Avg between rounds
$11.3M/yr
Capital velocity
3.1 yr
On record since
2023
First round
4
Rounds on file
How it compares to the market

Benchmarked against 233 companies in Medical Devices. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 10× above median
This company$26.0M
Sector median$2.6M
Latest round — vs other Series A rounds in sector (real $, this stage) 3.2× above median
This company$14.5M
Sector median$4.6M
Modeled value — vs sector median (estimate, all stages) 2.9× above median
This company$44.1M
Sector median$15.4M

Raised more than 90% of sector peers (real $). Modeled value above 75% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #1 of 10.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)Gestalt Diagnostics, LLC · Series A Raised $9.6M · modeled $25.2M (est)ClearCut Surgical, Inc. · Series A Raised $4.5M · modeled $15.2M (est)Bayou Surgical, Inc. · Series A Raised $13.2M · modeled $14.8M (est)AI Diagnostics · Series A Raised $5.2M · modeled $12.7M (est)NexEos Diagnostics, Inc. · Series A Raised $25.7M · modeled $7.9M (est)ReadySet Surgical, Inc. · Series A Raised $9.9M · modeled $7.6M (est)Black Light Surgical, Inc. · Series A Raised $12.9M · modeled $6.9M (est)EDGe Surgical, Inc. · Series A Raised $10.2M · modeled $3.6M (est)Surgical Center of Greensboro, LLC · Series A Raised $12.4M · modeled $2.9M (est)Curadel Surgical Innovations, Inc. (this company) Raised $26.0M · modeled $44.1M (est)Curadel Surgical Innovations, Inc.
CompanyStageRaised · realValue · estvs peer med.
Curadel Surgical Innovations, Inc. this companySeries A$26.0M$44.1M4.27×
Gestalt Diagnostics, LLCSeries A$9.6M$25.2M2.44×
ClearCut Surgical, Inc.Series A$4.5M$15.2M1.47×
Bayou Surgical, Inc.Series A$13.2M$14.8M1.43×
AI DiagnosticsSeries A$5.2M$12.7M1.23×
NexEos Diagnostics, Inc.Series A$25.7M$7.9M0.77×
ReadySet Surgical, Inc.Series A$9.9M$7.6M0.74×
Black Light Surgical, Inc.Series A$12.9M$6.9M0.66×
EDGe Surgical, Inc.Series A$10.2M$3.6M0.35×
Surgical Center of Greensboro, LLCSeries A$12.4M$2.9M0.28×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.0M2023-06-05$10.0M$15.1M90%
Series A$7.5M2024-09-04$34.1M$34.7M90%
Series A$9.5M2024-09-04$43.3M$44.1M90%
Series A$14.5M2025-09-25$65.8M$44.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.0M2023-06-05
    • First recorded raise — entered as Seed.
    • 10 investors on this round.
  2. Series A$7.5M2024-09-04
    • Raised 15 mo later, in step with the ~16 mo sector norm.
    • Round 3.8× larger than the prior — scaling up.
    • 24 investors on this round.
  3. Series A$9.5M2024-09-04
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 27 investors on this round.
  4. Series A$14.5M2025-09-25
    • Raised 13 mo later, in step with the ~16 mo sector norm.
    • Round 1.5× larger than the prior — scaling up.
    • 25 investors on this round.
Intelligence
2026 ~Q3
Modeled next raise · ~9mo cadence
$22.0M
Modeled next size est.range $14.5M$35.2M
1.5×
Last step-up
$11.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
GAREN V. BOHLIN2023-06
HENRY V. KAY2023-06
John V. Frangioni, M.D., Ph.D.2023-06
MARC V. GARNICK2023-06
WALID V. FAKHRY2023-06
Registry & provenance

Curadel Surgical Innovations, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1976619
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
NexEos Diagnostics, Inc.Medical DevicesSeries A$25.7M$7.9Msame sector · same stage
Vida Diagnostics IncMedical DevicesSeries A$32.0M$73.8Msame sector · same stage
Acuamark Diagnostics, Inc.Medical DevicesSeries A$20.3M$25.6Msame sector · same stage
Checkpoint Surgical, Inc.Medical DevicesSeries A$35.2M$20.8Msame sector · same stage
Ideal Implant IncMedical DevicesSeries A$16.8M$49.4Msame sector · same stage
New View Surgical, Inc.Medical DevicesSeries A$15.8M$70.8Msame sector · same stage
Prescient Surgical, Inc.Medical DevicesSeries A$15.6M$3.5Msame sector · same stage
MBio Diagnostics, Inc.Medical DevicesSeries A$45.3M$77.4Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Surgical Innovation Associates Inc.Medical DevicesSeries A$86.9M83%
IC Surgical, Inc.Medical DevicesPre-Seed$5.5M80%
Innovative Surgical Designs, Inc.ManufacturingSeries A$5.0M80%
CAIRA Surgical CorpMedical DevicesSeries A$85.4M80%
Vega Surgical, Inc.Medical DevicesPre-Seed$1.3M80%
EDGe Surgical, Inc.Medical DevicesSeries A$3.6M80%
Pace Surgical, Inc.Medical DevicesSeed$3.4M79%
Surgical Safety Technologies Inc.Medical DevicesSeries B$70.3M79%
Frequently asked
How much funding has Curadel Surgical Innovations, Inc. raised?
Curadel Surgical Innovations, Inc. has raised approximately $26.0M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Curadel Surgical Innovations, Inc.'s estimated valuation?
Provath's modeled valuation for Curadel Surgical Innovations, Inc. is approximately $44.1M (modeled range $17.8M–$71.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Curadel Surgical Innovations, Inc. at?
Curadel Surgical Innovations, Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Thu Sep 25.
What does Curadel Surgical Innovations, Inc. do and where is it based?
Curadel Surgical Innovations, Inc. operates in the Medical Devices sector, based in Bonita Springs.
Explore related

See where Curadel Surgical Innovations, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Curadel Surgical Innovations, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.